Advanced Enzyme Technologies Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Advanced Enzyme Technologies şirketinin toplam hissedar öz sermayesi ₹13.9B ve toplam borcu ₹256.9M olup, bu da borç-öz sermaye oranını 1.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹15.5B ve ₹1.6B dir. Advanced Enzyme Technologies 'in FAVÖK'ü ₹1.7B faiz karşılama oranı -16.8 dur. Şirketin ₹5.1B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
1.8%
Borç/özkaynak oranı
₹256.89m
Borç
| Faiz karşılama oranı | -16.8x |
| Nakit | ₹5.07b |
| Eşitlik | ₹13.89b |
| Toplam yükümlülükler | ₹1.60b |
| Toplam varlıklar | ₹15.49b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar
Aug 20
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now
Jul 19Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: ADVENZYMES 'nin kısa vadeli varlıkları ( ₹8.1B ) kısa vadeli yükümlülüklerini ( ₹1.0B ) aşıyor.
Uzun Vadeli Yükümlülükler: ADVENZYMES şirketinin kısa vadeli varlıkları ( ₹8.1B ) uzun vadeli yükümlülüklerini ( ₹564.4M ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: ADVENZYMES şirketinin toplam borcundan daha fazla nakiti var.
Borcun Azaltılması: ADVENZYMES 'nin borç/öz sermaye oranı son 5 yılda 2.5% seviyesinden 1.8% seviyesine düştü.
Borç Kapsamı: ADVENZYMES 'nin borcu işletme nakit akışı ( 553.6% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: ADVENZYMES ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.